Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (81-90 of 423) with videos related to

Pageof 43
Sort By:
The World Allergy Organization Journal|August 19, 2022
Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantationKarl-Christian Bergmann, Jörg-Wilhelm Oestmann, Jean Bousquet, et al.
Biomolecules|September 27, 2025
Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast CellsZhuoran Li, Jean Schneikert, Gürkan Bal, et al.
Health Science Reports|December 19, 2024
Evaluating the Impact of Laundry Detergents on the Skin Microbiome of Atopic Dermatitis Patients-A Clinical StudyDemetrios Christou, Katarina Stevanovic, Stefan Evers, et al.
International Journal of Molecular Sciences|February 25, 2023
CREB Is Activated by the SCF/KIT Axis in a Partially ERK-Dependent Manner and Orchestrates Survival and the Induction of Immediate Early Genes in Human Skin Mast CellsKristin Franke, Gürkan Bal, Zhuoran Li, et al.
Current Opinion in Allergy and Clinical Immunology|August 14, 2012
The role of interleukin-1 in allergy-related disordersKaroline Krause, Martin Metz, Michael Makris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization scheduleLars Meyer, Torsten Zuberbier, Margitta Worm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2023
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and BiologicsTorsten Zuberbier, Jonny Peter, Petra Staubach, et al.
Experimental Dermatology|August 10, 2018
MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in cultureMagda Babina, Zhao Wang, Metin Artuc, et al.
Current Opinion in Allergy and Clinical Immunology|June 27, 2020
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseasesFatih A Topal, Torsten Zuberbier, Michael P Makris, et al.
Clinical and Translational Allergy|October 16, 2025
A Novel Cell Culture System to Improve MRGPRX2 Research in Human Skin Mast CellsZhuoran Li, Jean Schneikert, Anja Wegner, et al.
Pageof 43

Showing results (81-90 of 423) with videos related to

Sort By:
Pageof 43
The World Allergy Organization Journal|August 19, 2022
Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantationKarl-Christian Bergmann, Jörg-Wilhelm Oestmann, Jean Bousquet, et al.
Biomolecules|September 27, 2025
Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast CellsZhuoran Li, Jean Schneikert, Gürkan Bal, et al.
Health Science Reports|December 19, 2024
Evaluating the Impact of Laundry Detergents on the Skin Microbiome of Atopic Dermatitis Patients-A Clinical StudyDemetrios Christou, Katarina Stevanovic, Stefan Evers, et al.
International Journal of Molecular Sciences|February 25, 2023
CREB Is Activated by the SCF/KIT Axis in a Partially ERK-Dependent Manner and Orchestrates Survival and the Induction of Immediate Early Genes in Human Skin Mast CellsKristin Franke, Gürkan Bal, Zhuoran Li, et al.
Current Opinion in Allergy and Clinical Immunology|August 14, 2012
The role of interleukin-1 in allergy-related disordersKaroline Krause, Martin Metz, Michael Makris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization scheduleLars Meyer, Torsten Zuberbier, Margitta Worm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2023
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and BiologicsTorsten Zuberbier, Jonny Peter, Petra Staubach, et al.
Experimental Dermatology|August 10, 2018
MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in cultureMagda Babina, Zhao Wang, Metin Artuc, et al.
Current Opinion in Allergy and Clinical Immunology|June 27, 2020
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseasesFatih A Topal, Torsten Zuberbier, Michael P Makris, et al.
Clinical and Translational Allergy|October 16, 2025
A Novel Cell Culture System to Improve MRGPRX2 Research in Human Skin Mast CellsZhuoran Li, Jean Schneikert, Anja Wegner, et al.
Pageof 43